Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1325, pseudogene (RNU6-1325P) is a human pseudogene derived from the highly conserved U6 small nuclear RNA (snRNA) gene family. U6 snRNAs are essential components of the spliceosome and crucial for pre-mRNA splicing, but this pseudogene does not encode a functional U6 snRNA[1][5]. Pseudogenes like RNU6-1325P typically arise from gene duplication or retrotransposition events and are usually nonfunctional; however, some pseudogenes can be transcribed and may regulate gene expression of their functional counterparts or other genes at the RNA level, for example as microRNA decoys or sources of regulatory RNAs[2]. There is currently no evidence that RNU6-1325P itself participates in coding, regulatory, disease, or drug response pathways, and it is not considered a therapeutic target[1][2].\n\nClarifications:\n- This gene is a pseudogene, not a coding gene, receptor, enzyme, transporter, or drug target[1].\n- The name and abbreviation are correct, but clinically relevant, disease, or therapeutic information for this particular entry is lacking.\n- Many vertebrate genomes contain multiple U6 pseudogenes; most serve as evolutionary remnants with no established individual function[5]. Some pseudogenes can have regulatory roles in exceptional cases, but such evidence does not exist for RNU6-1325P[2][1].\n- No drugs are known or hypothesized to interact with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1325, pseudogene (RNU6-1325P).